# Hybrid APC Therapy in Early Central Lung Neoplasms

> **NCT03537378** · NA · COMPLETED · sponsor: **Jiayuan Sun** · enrollment: 15 (actual)

## Conditions studied

- Lung Neoplasms

## Interventions

- **PROCEDURE:** Hybrid APC

## Key facts

- **NCT ID:** NCT03537378
- **Lead sponsor:** Jiayuan Sun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-26
- **Primary completion:** 2022-02-22
- **Final completion:** 2023-12-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-07-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03537378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03537378, "Hybrid APC Therapy in Early Central Lung Neoplasms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03537378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*